{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:30:13Z","timestamp":1789475413227,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ackdjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1053\/j.ackd.2016.03.008","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T10:30:38Z","timestamp":1466245838000},"page":"262-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today?"],"prefix":"10.1053","volume":"23","author":[{"given":"Michal L.","family":"Melamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupinder Singh","family":"Buttar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Coco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ackd.2016.03.008_bib1","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2016.03.008_bib2","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2016.03.008_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2215\/CJN.03050608","article-title":"Association of serum intact parathyroid hormone with lower estimated glomerular filtration rate","volume":"4","author":"Muntner","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib4","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"76","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.ackd.2016.03.008_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000096407","article-title":"The new KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and CKD","volume":"25","author":"Nelson","year":"2007","journal-title":"Blood Purif"},{"key":"10.1053\/j.ackd.2016.03.008_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2016.03.008_bib7","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ahj.2013.02.014","article-title":"Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies","volume":"165","author":"van Ballegooijen","year":"2013","journal-title":"Am Heart J"},{"key":"10.1053\/j.ackd.2016.03.008_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD\u2014the OPERA trial","volume":"25","author":"Wang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"key":"10.1053\/j.ackd.2016.03.008_bib11","first-page":"1","article-title":"Vitamin D status: United States, 2001-2006","author":"Looker","year":"2011","journal-title":"NCHS Data Brief"},{"key":"10.1053\/j.ackd.2016.03.008_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.ajkd.2014.05.018","article-title":"25-Hydroxyvitamin D testing and supplementation in CKD: an NKF-KDOQI controversies report","volume":"64","author":"Kramer","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2016.03.008_bib13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1525-139X.2007.00302.x","article-title":"Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3)","volume":"20","author":"Jones","year":"2007","journal-title":"Semin Dial"},{"key":"10.1053\/j.ackd.2016.03.008_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2016.03.008_bib15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2353\/ajpath.2010.091292","article-title":"Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats","volume":"177","author":"Kong","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ackd.2016.03.008_bib16","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"key":"10.1053\/j.ackd.2016.03.008_bib17","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1681\/ASN.2009030283","article-title":"25-hydroxyvitamin D levels, race, and the progression of kidney disease","volume":"20","author":"Melamed","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib18","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2215\/CJN.00910113","article-title":"25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system","volume":"8","author":"Fernandez-Juarez","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1681\/ASN.2014090947","article-title":"Normal 25-hydroxyvitamin D levels are associated with less proteinuria and attenuate renal failure progression in children with CKD","volume":"27","author":"Shroff","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib20","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2215\/CJN.02640311","article-title":"Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate","volume":"6","author":"de Boer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.ajkd.2015.08.026","article-title":"Biomarkers of vitamin D status and risk of ESRD","volume":"67","author":"Rebholz","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2016.03.008_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2016.03.008_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ndt\/gft360","article-title":"The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study","volume":"29","author":"Molina","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2016.03.008_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","article-title":"Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials","volume":"6","author":"Kandula","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib25","first-page":"CD005633","article-title":"Vitamin D compounds for people with chronic kidney disease requiring dialysis","author":"Palmer","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.ackd.2016.03.008_bib26","first-page":"CD008175","article-title":"Vitamin D compounds for people with chronic kidney disease not requiring dialysis","author":"Palmer","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.ackd.2016.03.008_bib27","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ahj.2012.09.018","article-title":"Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease","volume":"164","author":"Tamez","year":"2012","journal-title":"Am Heart J"},{"key":"10.1053\/j.ackd.2016.03.008_bib28","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ki.2011.207","article-title":"Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate","volume":"80","author":"Agarwal","year":"2011","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2016.03.008_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2005.04.013","article-title":"Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis","volume":"46","author":"Charytan","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2016.03.008_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2008.09.021","article-title":"A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis","volume":"53","author":"Chonchol","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2016.03.008_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1523-1755.2005.67103.x","article-title":"Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism","volume":"67","author":"Colloton","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2016.03.008_bib32","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","article-title":"Arterial calcification in chronic kidney disease: key roles for calcium and phosphate","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ Res"},{"key":"10.1053\/j.ackd.2016.03.008_bib34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/j.ajkd.2008.08.009","article-title":"Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study","volume":"53","author":"Menon","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2016.03.008_bib35","first-page":"CD001892","article-title":"Low protein diets for chronic kidney disease in non diabetic adults","author":"Fouque","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.ackd.2016.03.008_bib36","first-page":"CD002181","article-title":"Protein restriction for diabetic renal disease","author":"Robertson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.ackd.2016.03.008_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease","volume":"6","author":"Moe","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib38","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib39","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1053\/j.ajkd.2015.03.036","article-title":"Association of drug effects on serum parathyroid hormone, phosphorus, and calcium levels with mortality in CKD: a meta-analysis","volume":"66","author":"Palmer","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2016.03.008_bib40","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib41","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"382","author":"Jamal","year":"2013","journal-title":"Lancet"},{"key":"10.1053\/j.ackd.2016.03.008_bib42","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/ndt\/gft203","article-title":"A comparison of calcium acetate\/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study","volume":"28","author":"Covic","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2016.03.008_bib43","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2215\/CJN.05170513","article-title":"Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD","volume":"9","author":"Yokoyama","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2008020159","article-title":"Timing of onset of CKD-related metabolic complications","volume":"20","author":"Moranne","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib45","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1523-1755.2004.00481.x","article-title":"Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease","volume":"65","author":"Eustace","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2016.03.008_bib46","first-page":"S1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.ackd.2016.03.008_bib47","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.ajkd.2014.07.007","article-title":"Serum bicarbonate and bone mineral density in US adults","volume":"65","author":"Chen","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2016.03.008_bib48","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1210\/jc.2014-4166","article-title":"Arterialized venous bicarbonate is associated with lower bone mineral density and an increased rate of bone loss in older men and women","volume":"100","author":"Tabatabai","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.ackd.2016.03.008_bib49","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI112020","article-title":"Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3","volume":"76","author":"Nath","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2016.03.008_bib50","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.ajkd.2009.02.014","article-title":"Serum bicarbonate levels and the progression of kidney disease: a cohort study","volume":"54","author":"Shah","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2016.03.008_bib51","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2215\/CJN.03730411","article-title":"Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease","volume":"6","author":"Navaneethan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib52","doi-asserted-by":"crossref","first-page":"E719","DOI":"10.1503\/cmaj.120438","article-title":"Plasma bicarbonate and risk of type 2 diabetes mellitus","volume":"184","author":"Mandel","year":"2012","journal-title":"CMAJ"},{"key":"10.1053\/j.ackd.2016.03.008_bib53","doi-asserted-by":"crossref","unstructured":"Dobre M, Yang W, Pan Q, et al. Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): a report from the Chronic Renal Insufficiency Cohort (CRIC) study. J Am Heart Assoc. http:\/\/dx.doi.org\/10.1161\/JAHA.114.001599 [Epub ahead of print].","DOI":"10.1161\/JAHA.114.001599"},{"key":"10.1053\/j.ackd.2016.03.008_bib54","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ki.2009.519","article-title":"Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR","volume":"77","author":"Phisitkul","year":"2010","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2016.03.008_bib55","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1681\/ASN.2008111205","article-title":"Bicarbonate supplementation slows progression of CKD and improves nutritional status","volume":"20","author":"de Brito-Ashurst","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ki.2011.313","article-title":"Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy","volume":"81","author":"Goraya","year":"2012","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2016.03.008_bib57","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2215\/CJN.02430312","article-title":"A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate","volume":"8","author":"Goraya","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2016.03.008_bib58","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2215\/CJN.08340812","article-title":"Effects of oral sodium bicarbonate in patients with CKD","volume":"8","author":"Abramowitz","year":"2013","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154855951630012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154855951630012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:56:27Z","timestamp":1536627387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154855951630012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S154855951630012X"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2016.03.008","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today?","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2016.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}